In an effort to understand the contribution of the primer-binding site (PBS) region to human immunodeficiency virus (HIV) replication, we have constructed a mutant HIV proviral DNA with an alteration in the 5' end of the PBS. The PBS mutant proviral DNA was characterized by transfection of the viral DNA into CD4' and non-CD4' target cells.
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The results indicate that mutation in the PBS reduced the level of viral particles released into the medium of transfected cells in comparison to wild-type proviral DNA. The viral particles were noninfectious upon transmission to established CD4' cell lines and phytohemagglutinin-stimulated peripheral blood lymphocytes. Electron microscopic analysis of the transfected cells revealed no abnormalities in the structure of the virion directed by the mutant proviral DNA. Also, the protein and RNA contents of the mutant virions were similar to the wild type. The quantitation of intracellular viral structural protein in the transfected cells, however, indicated that the PBS mutation may have an effect on the assembly of viral particles in addition to completely abolishing reverse transcription of viral RNA into DNA. These results provide evidence that the PBS region of the viral genome has multiple functions in HIV-I replication.
The genome of human immunodeficiency virus type 1 (HIV-1), like other members of the lentivirus family, encodes not only the virion proteins gag, pol, and env common to all replication-competent retroviruses but also eight accessory genes, some of which are involved in the gene regulation and morphogenesis of HIV (1) (2) (3) . Biochemical and structural studies have revealed that HIV is about 80-120 nm in diameter and consists of an inner core (nucleoid) surrounded by an outer envelope. The core corresponds to a ribonucleoprotein surrounded by the capsid protein. The viral RNA genome is in the ribonucleoprotein, and it is composed of two identical positive-sense RNAs with a 5' cap and a 3' poly(A) structure (4) .
The replication cycle of HIV-1 and other retroviruses involves the reverse transcription of virion RNA to viral DNA, which then becomes incorporated into the host cellular genome. The reverse transcription is mediated by the virionassociated enzyme reverse transcriptase (RT) (5, 6) . As with all DNA polymerases, RT needs a primer covering a 3' hydroxyl (OH) group to initiate cDNA synthesis. The in vivo primer for the viral first-strand cDNA synthesis from an RNA template has been shown to be tRNA (6) . A region near the 5' end of the viral RNA genome designated as the primerbinding site (PBS) is complementary to the 18 nucleotides of the 3' CCA end of the specific tRNA primer. Predominantly, many mammalian retroviruses use proline tRNA, and avian retroviruses make use of tryptophan tRNA. Sequence analysis of HIV-1 revealed PBS corresponding to the lysine tRNA as in other lentiviruses (7) . It has also been recently demonstrated that HIV RT forms a stable complex with isoacceptor 3 of lysine tRNA (Lys3 tRNA) (8) , as has been demonstrated for the RT enzyme of avian viruses.
Initiation of viral DNA synthesis is a crucial step in the replication of retroviruses, and the essential PBS is embedded in the complex structure ofRNA (9) . A number of studies have reported the importance of the secondary structure of the genome at the 5' end in the assembly and infectivity of the virus (10) (11) (12) . In an effort to understand the structural requirement of the PBS in reverse transcription and virus morphogenesis, we have introduced an insertional mutation in the PBS of HIV-1. The results obtained with the PBS mutant imply that the PBS region, in addition to its participation in reverse transcription, is also involved in the assembly of viral particles.
MATERIALS AND METHODS
Cell Lines. A human rhabdomyosarcoma (RD) cell line (American Type Culture Collection) was maintained as a monolayer culture in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, penicillin (100 units/ml), and L-glutamine (540 pug/ml) at 370C with 5% CO2. CEM x 174 and HUT78 cells were maintained as suspension cultures in RPMI 1640 medium; phytohemagglutininstimulated (10 Ag/ml) peripheral blood lymphocytes were grown in RPMI 1640 medium containing T-cell growth factor (10%).
Construction of the PBS Mutant. The HIV proviral DNA plasmid designated pARV was derived from cells infected with HIVSF2 (13) . The pARV plasmid was cleaved with the restriction enzyme Nar I, and the resultant linear molecule was purified by agarose gel electrophoresis. The Nar I overhang sequence in the DNA was filled in by using Klenow polymerase and ligated by using T4 ligase (14) . The recombinant plasmid obtained from the transformed colonies was checked for the presence of the Nar I cleavage site. The plasmid (pARV-NAR) lacking the Nar I site was further confirmed by sequence analysis with a Sequenase kit (United States Biochemical).
Transfection. RD cells (1 x 106 cells per plate) were split 24 hr before transfection, and growth medium was replaced 1-2 hr before the addition of calcium phosphate-precipitated DNA (15) . Cells were exposed to the precipitate for 8 hr followed by a 90-sec glycerol shock (16 (22) .
Nucleic Acid Analysis. The virus from the medium were lysed and ir lulose paper and hybridized to the length viral DNA (23, 24) . For The cell-free medium and (Table 3 ).
-positive patient sera and
The viral particles released from the transfected cultures re fixed for EM with 2.5% infectivity potential. Since our previous emixm edtfordEM studies (27) and others (28) in used, similar levels of RT activity were noted (Fig. 3A) . (107) were transfected with 10 jig of wild-type pARV or mutant pARV-NAR by the DEAE-dextran method as described in the text. The level of p24 antigen released into the medium was monitored at different intervals (every 3-5 days) after transfection. The cut-off value for this experiment was 7 pg/ml. However, when RT activity was monitored in the absence of an exogenous template primer, only the wild-type virus showed considerable activity (Fig. 3B) . These results clearly indicate that the mutant virus is unable to initiate reverse transcription in an endogenous assay. Analysis of Viral Proteins. The differences in the extracellular and intracellular p24 antigen levels prompted us to analyze the viral proteins in the transfected cells. The low level of virus production observed in the mutant DNAtransfected cells could result from a defect in the gag and envelope protein synthesis and/or processing. The intracellular synthesis of viral proteins was analyzed by using radioimmunoprecipitation analysis (RIPA virus, murine leukemia virus, spleen necrosis virus, and HIV has indicated that the tRNA primer may, in each case, be positioned within an extensive RNA structure (11, 12) . Cobrinik et al. (10) provided genetic evidence that the secondary structures in the 5' end of the genome of avian retroviruses are critical for replication and efficient growth. Sequence analyses of the PBS in a number of HIV-1 isolates indicate that the PBS is highly conserved, and only minimal changes were noted in the 3' end of the PBS.
In this report, we present evidence that the PBS has multiple functions; it provides a target for anchoring tRNA primer and also participates in virion morphogenesis. For assessing the effect of the PBS mutation, both wild-type and (lanes 2 and 4). mutant proviral DNA were transfected into CD4+ CEM x 174 cells. This experimental system relies on the ability ofthe virus to initiate a new infection upon release from the transfected cells. Generally, a high amount of RT activity or viral antigen is observed after 10-15 days. The results generated by using this system clearly indicated that the virus released by mutant proviral DNA is noninfectious because there was no spreading infection.
To characterize the effect of the PBS mutation on virus production, we have used monolayer cells as target cells for transfection of proviral DNA. We and others (24, 25, 27, 28) have extensively used human RD cells, as a transient system, to generate HIV upon transfection. These target cells lack CD4 receptors on the cell surface, and this feature enables absolute quantitation of virus released from the transfected cells. PBS mutant proviral DNA showed a low level of virus production in comparison to the wild-type DNA. These results are in sharp contrast to the data recently reported by Rhim et al. (32) involving deletion mutational analysis of the PBS. The difference between our data and that of Rhim et al. (32) may be due to the difference in the cell system used for transfection studies. In RD cells, HIV has been shown to bud from the cell surface as observed in H9, MOLT-3, MOLT-4, and CEM cells (4) . The reduced level of virus production observed could result from a number of events including transcription, RNA stability, translation, and posttranslational processing. The quantitation of the viral structural protein p24, in the form of viral particles released into the medium, showed low levels from mutant DNA-transfected cells. However, the levels of intracellular structural protein of the virus remained the same in both the mutant and wild-type DNA transfected cells, indicating a possible defect in any one of the steps associated with the virion assembly. It has been reported that the RT enzyme and nucleocapsid protein participate in the selection and binding of the tRNA primer to the PBS in the genomic RNA. The leader and replication primer tRNA are highly structured, and hybridization seems unlikely without disruption of secondary structures. A role for the nucleocapsid protein in the unwinding of the RNA structure, which promotes a base pairing interaction between complementary sequences, has been reported (8, 9) . In the presence of RT, in addition to nucleocapsid protein, tRNA binds more efficiently to the PBS. It is possible that the PBS mutation interferes with this process, which results in diminished virion morphogenesis.
Concomitant to the data observed in CEM x 174 cells, virus released from the monolayer cells was noninfectious in an assay involving cocultivation of CEM x 174 cells with proviral DNA-transfected RD cells. The lack of infectivity of the virus could result from impaired processing of viral proteins. Studies have shown that the cleavage of the env precursor gpl60 into the gpl2O-gp41 heterodimer is critical for infectivity (33) . HIV particles containing uncleaved gpl60 due to a mutation are not infectious. Similarly, the HIVspecific protease has to process the p55aag precursor to render the assembled particles infectious (34, 35 The protein profile was similar in both wild-type and PBS mutant DNA-transfected cells.
Biochemical analysis of the viral particles directed by the PBS mutant proviral DNA was carried out to understand the basis of the noninfectious nature of the virus. Hybridization analysis of the viral particles utilizing the probes specific for the HIV-1 genome and the lysine tRNA primer showed that packaging of the viral RNA and the tRNA primer is not affected. The viral particles derived from the PBS mutant were also characterized for the presence of functional RT enzyme. Although functional RT enzyme was detected by using an exogenous template primer, endogenous reverse transcription with the PBS mutant virus was negligible. These results indicated that there is a block at the initiation of reverse transcription in the mutant virus.
The PBS mutation analyzed in this study contains a 2-base insertion, which is located 5 bases downstream of the 5' end of the PBS. Even though there is evidence for the use of truncated tRNA primers (36) (37) (38) or incorrectly processed tRNA (39) , the insertion of 2 bases completely eliminated the PBS function in reverse transcription. Because of the homology, tRNA anneals efficiently to the genomic RNA PBS and is able to initiate the reverse transcription process in the wild type (Fig. 6A) . The lack of endogenous reverse transcription in the mutant virions could be attributed to two possible mechanisms, as depicted in Fig. 6 B and C. In the first model (Fig. 6B) , the tRNA primer binds to the genomic RNA, leaving nonhomologous mutant sequences in the PBS as a bulge, which would then lead to successful initiation of reverse transcription. The results obtained with endogenous reverse transcription, however, were in favor of the second model (Fig. 6C) , where binding occurs only at the 3' end of PBS with the tRNA molecule. The nonhomology at the5' end of PBS, because of the insertion of bases, leaves the 3' OH termini of the tRNA primer ineffective in priming. Such an observation has also been noted with oligonucleotide primers in the polymerase chain reaction (40) .
The exact mechanisms by which alteration in the PBS affects virus production are not known. The observations of increased levels of structural protein p24 inside the cells, dissimilar levels of virus released into the cultural medium of the proviral DNA-transfected cells, and the noninfectious nature of the virus produced by the mutant (pARV-NAR) suggest that the PBS mutation possibly interferes with the processes associated with the virion morphogenesis in addition to abolishing reverse transcription. These results support the notion that the PBS region of the retroviral genome has multiple functions in retrovirus replication (41, 42) . Additionally, the noninfectious HIV-1 resulting from the PBS mutation provides an important alternative source of immunization of animals for evaluating vaccine strategies.
